Author:
Ono Makiko,Ando Masashi,Yonemori Kan,Yamamoto Harukaze,Hirata Taizo,Shimizu Chikako,Tamura Kenji,Katsumata Noriyuki,Fujiwara Yasuhiro
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference18 articles.
1. Briasoulis E, Kalofonos H, Bafaloukos D, Samantas E, Fountzilas G, Xiros N, Skarlos D, Christodoulou C, Kosmidis P, Pavlidis N (2000) Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic cooperative oncology group study. J Clin Oncol 18(17):3101–3107
2. Briasoulis E, Pavlidis N, Felip E (2008) Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up. Ann Oncol 19(Suppl 2):ii106–107. doi: 10.1093/annonc/mdn104
3. Bridgewater J, van Laar R, Floore A, Van TVL (2008) Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary. Br J Cancer 98(8):1425–1430. doi: 10.1038/sj.bjc.6604315
4. Culine S, Ychou M, Fabbro M, Romieu G, Cupissol D (2001) 5-fluorouracil and leucovorin as second-line chemotherapy in carcinomas of unknown primary site. Anticancer Res 21(2B):1455–1457
5. Hainsworth JD, Greco FA (1993) Treatment of patients with cancer of an unknown primary site. N Engl J Med 329(4):257–263. doi: 10.1056/NEJM199307223290407
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献